<i>In vivo</i> effects of the 5‐HT₃ antagonist alosetron on basal and cholera toxin‐induced secretion in the human jejunum: a segmental perfusion study

Abstract

The 5-hydroxytyptamine type 3 receptor antagonist, alosetron, increased basal fluid absorption in normal human small intestine but failed to have a beneficial effect in cholera toxin-induced secretion.